Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 批发和零售业
Company Introduction 云南鸿翔一心堂药业(集团)股份有限公司所处的行业为医药流通行业,主营业务为中、西成药品零售连锁,其中医药零售连锁是公司的核心业务.公司主要经营范围包括中药、西药及医疗器械等产品的经营销售,主要收入来源为连锁直营门店医药销售收入.鸿翔一心堂成立于2000年11月，经过十余年的发展，公司已经成为总资产超20亿元，年销售收入超35亿元，拥有2,389家直营连锁门店、580万会员的大型医药零售连锁企业，是云南省销售额最大、网点最多的药品零售企业。根据中国药店杂志公开发布数据，自2007年起，公司销售额及直营门店数连续七年进入中国连锁药店排行榜十强，近年来行业排名稳定在前10名，市场份额逐步扩大。2012年公司在中国药品零售企业竞争力排行榜排名第2位，2012年中国药品零售企业竞争力排行榜“七力单项冠军”中盈利力冠军6。
Main Business 医药零售连锁和医药批发业务，其中医药零售连锁是公司的核心业务。
Legal Representative 阮鸿献
Top Executives
董事长：阮鸿献
董事：张勇,阮国伟,徐科一,郭春丽,刘琼
独立董事：杨先明,陈旭东,龙小海
Top 5 Shareholder
Shareholder name Nature Holding Date
阮鸿献限售股+流通A股30.58%31/03/2024
刘琼限售股+流通A股11.33%31/03/2024
广州白云山医药集团股份有限公司流通A股5.18%31/03/2024
香港中央结算有限公司流通A股5.16%31/03/2024
中国工商银行股份有限公司－融通健康产业灵活配置混合型证券投资基金流通A股3.29%31/03/2024
Company Secretary 李正红
Solicitors 北京懋德律师事务所
Auditors 中审众环会计师事务所（特殊普通合伙）
Tel No 0871-68185283
Fax No 0871-68185283
Website www.hx8886.com
Email 002727ir@hxyxt.com
Company Address
Register: 云南省昆明市经济技术开发区鸿翔路1号
Office: 云南省昆明市经济技术开发区鸿翔路1号
Listing Date 02/07/2014
Shares Capital
Shares Capital: 596,005,425
Total A Share: 596,005,425
Listed A Share: 407,676,233
Non-tradable A Share: 188,329,192
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.921
DPS(RMB)* ¥ 0.400
NBV Per Share(RMB)* ¥ 12.996
Market Capitalization(RMB) 9.234B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.